• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在血压明显难以控制的患者中,普遍存在不遵医嘱的情况:一项系统性回顾和荟萃分析。

Nonadherence Is Common in Patients With Apparent Resistant Hypertension: A Systematic Review and Meta-analysis.

机构信息

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

University of Ottawa, Ottawa, Ontario, Canada.

出版信息

Am J Hypertens. 2023 Jun 15;36(7):394-403. doi: 10.1093/ajh/hpad013.

DOI:10.1093/ajh/hpad013
PMID:36715101
Abstract

BACKGROUND

The prevalence of medication nonadherence in the setting of resistant hypertension (RH) varies from 5% to 80% in the published literature. The aim of this systematic review was to establish the overall prevalence of nonadherence and evaluate the effect of the method of assessment on this estimate.

METHODS

MEDLINE, EMBASE, Cochrane, CINAHL, and Web of Science (database inception to November 2020) were searched for relevant articles. We included studies including adults with a diagnosis of RH, with some measure of adherence. Details about the method of adherence assessment were independently extracted by 2 reviewers. Pooled analysis was performed using the random effects model and heterogeneity was explored with metaregression and subgroup analyses. The main outcome measured was the pooled prevalence of nonadherence and the prevalence using direct and indirect methods of assessment.

RESULTS

Forty-two studies comprising 71,353 patients were included. The pooled prevalence of nonadherence was 37% (95% confidence interval [CI] 27%-47%) and lower for indirect methods (20%, 95% CI 11%-35%), than for direct methods (46%, 95% CI 40%-52%). The study-level metaregression suggested younger age and recent publication year as potential factors contributing to the heterogeneity.

CONCLUSIONS

Indirect methods (pill counts or questionnaires) are insufficient for diagnosis of nonadherence, and report less than half the rates as direct methods (direct observed therapy or urine assays). The overall prevalence of nonadherence in apparent treatment RH is extremely high and necessitates a thorough evaluation of nonadherence in this setting.

摘要

背景

在耐药性高血压(RH)的情况下,药物不依从的发生率在文献中从 5%到 80%不等。本系统评价的目的是确定不依从的总体发生率,并评估评估方法对该估计值的影响。

方法

在 MEDLINE、EMBASE、Cochrane、CINAHL 和 Web of Science(数据库建立至 2020 年 11 月)中搜索相关文章。我们纳入了诊断为 RH 的成年患者,并使用某种依从性测量方法的研究。由 2 位审阅者独立提取关于依从性评估方法的详细信息。使用随机效应模型进行汇总分析,并使用元回归和亚组分析探索异质性。主要结局测量是不依从的汇总发生率和直接和间接评估方法的发生率。

结果

共纳入 42 项研究,包含 71353 名患者。不依从的总体发生率为 37%(95%置信区间 [CI] 27%-47%),间接方法(20%,95%CI 11%-35%)的发生率低于直接方法(46%,95%CI 40%-52%)。研究水平的荟萃回归表明,年龄较小和最近的发表年份可能是导致异质性的因素。

结论

间接方法(计数药丸或问卷调查)不足以诊断不依从,报告的比率低于直接方法(直接观察治疗或尿液检测)的一半。在明显治疗 RH 中不依从的总体发生率极高,因此需要在这种情况下对不依从进行彻底评估。

相似文献

1
Nonadherence Is Common in Patients With Apparent Resistant Hypertension: A Systematic Review and Meta-analysis.在血压明显难以控制的患者中,普遍存在不遵医嘱的情况:一项系统性回顾和荟萃分析。
Am J Hypertens. 2023 Jun 15;36(7):394-403. doi: 10.1093/ajh/hpad013.
2
The Prevalence of Nonadherence in Patients With Resistant Hypertension: A Systematic Review Protocol.顽固性高血压患者不依从性的患病率:一项系统评价方案
Can J Kidney Health Dis. 2019 Dec 25;6:2054358119897196. doi: 10.1177/2054358119897196. eCollection 2019.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.明显治疗抵抗性高血压患者的药物依从性:系统评价与荟萃分析
J Hypertens. 2017 Dec;35(12):2346-2357. doi: 10.1097/HJH.0000000000001502.
5
Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta-Analysis Involving 27 Million Patients.2010 年至 2020 年期间全球范围内高血压药物治疗不依从的负担、地区差异、趋势及其对健康的影响:一项涉及 2700 万患者的荟萃分析
J Am Heart Assoc. 2022 Sep 6;11(17):e026582. doi: 10.1161/JAHA.122.026582. Epub 2022 Sep 3.
6
Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review.血液透析患者药物治疗的不依从性:一项系统评价
PLoS One. 2015 Dec 4;10(12):e0144119. doi: 10.1371/journal.pone.0144119. eCollection 2015.
7
Socioeconomic status and nonadherence to antihypertensive drugs: a systematic review and meta-analysis.社会经济地位与抗高血压药物不依从性:系统评价和荟萃分析。
Value Health. 2014 Mar;17(2):288-96. doi: 10.1016/j.jval.2013.11.011.
8
Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations.治疗的高血压人群中难治性高血压患病率的系统评价和荟萃分析。
Am J Hypertens. 2015 Mar;28(3):355-61. doi: 10.1093/ajh/hpu151. Epub 2014 Aug 25.
9
Predictors of nonadherence to statins: a systematic review and meta-analysis.他汀类药物不依从的预测因素:系统评价和荟萃分析。
Ann Pharmacother. 2010 Sep;44(9):1410-21. doi: 10.1345/aph.1P150. Epub 2010 Aug 11.
10
Resistant hypertension-defining the scope of the problem.耐药性高血压——定义问题的范围。
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):46-50. doi: 10.1016/j.pcad.2019.12.006. Epub 2019 Dec 19.

引用本文的文献

1
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
2
Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice.常规临床实践中管理新诊断的轻至中度高血压患者的简化方法
Adv Ther. 2025 Feb;42(2):1108-1130. doi: 10.1007/s12325-024-03091-6. Epub 2024 Dec 28.
3
Patient Engagement in a Hybrid Care Pathway for Hypertension: Not One Size Fits All.
高血压混合护理路径中的患者参与:并非一概而论。
J Patient Exp. 2024 Dec 8;11:23743735241297626. doi: 10.1177/23743735241297626. eCollection 2024.
4
Chemical adherence testing in the clinical management of hypertension: a scoping review.高血压临床管理中的化学黏附测试:一项范围综述
Front Pharmacol. 2024 Nov 6;15:1452464. doi: 10.3389/fphar.2024.1452464. eCollection 2024.
5
[Not Available].[无可用内容]。
CMAJ. 2024 Oct 21;196(35):E1210-E1211. doi: 10.1503/cmaj.240206-f.
6
How to deal with a hypertensive patient who has documented non-adherence to the prescribed antihypertensive therapy?如何处理已记录显示不依从规定抗高血压治疗方案的高血压患者?
Hypertens Res. 2024 Oct;47(10):2914-2916. doi: 10.1038/s41440-024-01810-8. Epub 2024 Jul 26.
7
Resistant hypertension.顽固性高血压
CMAJ. 2024 Jul 28;196(26):E905. doi: 10.1503/cmaj.240206.
8
The Global Burden of Resistant Hypertension and Potential Treatment Options.难治性高血压的全球负担及潜在治疗方案
Eur Cardiol. 2024 Jun 19;19:e07. doi: 10.15420/ecr.2023.51. eCollection 2024.
9
Therapeutic Drug Monitoring and the Challenge of Conducting Trials to Improve Antihypertensive Medication Adherence.治疗药物监测与开展试验以改善抗高血压药物依从性面临的挑战。
Am J Hypertens. 2024 Sep 16;37(10):745-747. doi: 10.1093/ajh/hpae075.
10
RNA Interference as a Therapeutic Approach for Managing Hypertension.RNA干扰作为治疗高血压的一种方法。
Clin J Am Soc Nephrol. 2024 Feb 13;19(6):810-2. doi: 10.2215/CJN.0000000000000443.